Stevia Microneedle Patch May Boost Minoxidil for Baldness

Scientists are investigating a plant extract best known for sweetening diet foods and drinks. Early findings in animals indicate that it may improve one of the limited treatments currently available for baldness.

From fizzy drinks to hair follicles

The plant involved in this research is stevia, a natural sweetener first used by Indigenous peoples in South America, especially in Bolivia and Paraguay. It is now added by food manufacturers to fizzy drinks, yoghurts and ice creams to reduce sugar content without sacrificing sweetness.

Stevia has already prompted considerable discussion about how much people should consume, and that debate continues. However, the newest research considers an entirely different issue: its possible role in hair growth rather than its effect on waistlines.

Published in Advanced Healthcare Materials on 7 October 2025, the study examines stevioside, a naturally occurring compound in stevia. Rather than adding it to food, researchers incorporated it into a small medical device intended to tackle androgenetic alopecia, commonly known as male and female pattern baldness.

In bald mice, a 35‑day treatment containing a stevia derivative led to hair regrowth on roughly two‑thirds of the previously bare scalp.

Researchers shaved and chemically damaged areas of the mice's skin to create patches resembling bald scalp. Following a little over a month of treatment, around 67.5% of these previously almost smooth areas were covered by hair.

How a blood pressure medicine became a hair-loss treatment

The significance of this result becomes clearer with the unusual history of minoxidil. It was originally developed during the 1970s as a treatment for high blood pressure. Doctors then observed a striking side effect: certain patients developed thicker hair, including on their scalps.

Drug companies soon adapted minoxidil into topical lotions and foams for hair loss. It has since become one of the few broadly approved treatments for pattern baldness and is available without prescription in many countries.

Its principal limitation is the way it reaches the skin. When minoxidil is applied as a foam or liquid, it may not penetrate deeply or reliably enough. While some users achieve modest results, others gain almost no benefit. It also needs to be applied every day, often for months or years, leading many people to stop using it.

The new research does not replace minoxidil; it tries to help the drug get where it needs to go and stay there for longer.

Stevia's hidden role: microscopic needles made from a sweetener

The main advance in the study is a patch containing microscopic needles. Made from stevioside, the stevia-derived compound, these microneedles are loaded with minoxidil. Once pressed onto the scalp, they enter only the outer skin layers and do not reach deeper nerves or blood vessels.

The microneedles based on stevioside slowly dissolve, releasing minoxidil into the area around the hair follicles instead of allowing much of the medicine to remain inactive on the skin's surface.

What the new patch is intended to achieve

• Deliver minoxidil into the scalp directly through dissolving microneedles
• Gradually release the medicine for a longer-lasting effect
• Lessen the need for messy daily applications of liquid or foam
• Use biodegradable, plant-based material rather than plastic or metal

The study found that combining an established hair-loss medicine with a stevia-derived microneedle patch produced greater regrowth in mice than minoxidil by itself. Mice given the new patch developed denser and more evenly distributed hair over the treated areas.

The stevia-based microneedles functioned as a “booster system”, enhancing skin absorption of minoxidil and stretching out its activity over days rather than hours.

Why results in mice cannot guarantee human hair growth

As with any attention-grabbing claim about baldness, important limitations apply. So far, the experiments have only involved mice, not people. Mouse skin is thinner, their hair cycles are shorter, and medicines can act differently in their bodies.

In humans, pattern baldness is also linked to age, genetics and hormones. Although the mouse model recreated aspects of hair loss, it cannot reproduce the full complexity of human hair follicles.

The researchers emphasise that substantial further research is required before anybody considers using stevia-based patches on their scalp. Safety will need close assessment, including scalp reactions, the possibility of irritation or allergies following repeated treatment, and the effects on the wider body as the patch material dissolves.

For now, the study offers a proof of concept: plant-derived microneedles can carry a known hair drug deeper into the scalp and improve its effect in animals.

What this may mean for future baldness treatments

Even if this particular patch never becomes available from pharmacies, its underlying principle could alter the delivery of hair-loss medicines. If microneedles can safely deliver treatment nearer to hair follicles, smaller doses may be sufficient and side effects beyond the scalp may be reduced.

Treatment options for pattern baldness remain limited. They include:

• Topical minoxidil – applied to the scalp once or twice a day; it works for some people but not everyone.
• Finasteride tablets – generally prescribed to men; they can cause sexual and hormonal side effects.
• Hair transplant surgery – can be effective but is costly, invasive and unsuitable for everybody.
• Laser caps and devices – extensively marketed, although the evidence is mixed and frequently funded by the industry.

A minimally invasive patch with small dissolving needles could occupy a middle ground between everyday lotions and surgical treatment. Depending on the duration of drug release from the microneedles, it could potentially be used every few days or every few weeks.

Questions people with hair loss may ask

Will drinking stevia fizzy drinks encourage hair growth?

In brief, no. The encouraging findings involve minoxidil administered through microneedles made from a purified stevia compound and placed directly on the scalp. Stevia consumed in food or drink does not reach hair follicles in the same targeted way.

Dose, chemical form and delivery route are all important. Material passing through the digestive system is broken down and circulated throughout the body. The experimental patch avoids digestion and acts locally in the skin.

Could it work for women as well as men?

Androgenetic alopecia affects both sexes, although its patterns are different. Women are more likely to develop diffuse thinning than the familiar receding hairline. Because women already use minoxidil, a method that improves its effectiveness in the scalp could theoretically be relevant to both women and men.

Human trials would have to enrol both sexes and monitor variations in response, side effects and preferred dosing schedules.

Understanding key terms

Risks, unanswered questions and the next steps

Any device that breaks the skin, even mildly, raises concerns about inflammation, infection and long-term tolerability. As the stevia-derived needles dissolve, they avoid the risk of fragments snapping off and remaining in the skin. However, repeated use in the same locations will require careful testing.

Cost is another uncertainty. Should the patch depend on complicated manufacturing processes or highly purified plant compounds, it could cost more than existing lotions and foams. This may place it beyond the reach of many people unless insurers or public health services determine that it delivers clear benefits.

There is a psychological concern as well. People experiencing hair loss are often targeted with questionable products that promise implausible outcomes. Before robust human evidence is available, a plant-based, “high-tech” patch could easily be exaggerated in marketing and headlines.

For anyone tempted by early headlines, the safest course is to treat this as an intriguing early-stage technique, not a guaranteed cure sitting in the drinks aisle.

Practical possibilities if the patch eventually proves effective

If later human research verifies both safety and benefit, dermatologists could prescribe stevia-based microneedle patches alongside current treatments. Someone in their 30s who notices thinning around the crown, for instance, might receive patches every couple of weeks while using standard topical minoxidil between appointments.

People who find daily applications difficult to remember, or dislike the greasy texture of lotions, might choose patch-only treatment plans overseen by a clinic. The slow-release approach could result in fewer rises and falls in drug levels, potentially supporting more consistent hair maintenance.

Researchers could also modify the same microneedle technology to administer other medicines, including anti-inflammatory treatments for scalp conditions and experimental compounds aimed directly at hair-follicle signalling pathways.

For the moment, stevia's unexpected appearance in hair research is a reminder that refining the way an established medicine is delivered can sometimes be as compelling as creating an entirely new drug.